ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
New investors often wonder what to ask financial advisors. Discover essential questions that can lead to tailored advice and successful investing.
28,527 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Analysts spotlight five dividend stocks yielding above 5% designed to provide steady income amid market volatility. T...
MicroStrategy stock has jumped 43% in the last month as Bitcoin climbs. A new strategy price prediction: mstr model s...
This article explores Baupost founder Seth Klarman's patient, risk-conscious investing style. Learn how his focus on ...
KeyBanc lowers its price target for On Holding AG to $43, citing tariff exposure that weighs on margins, even as the ...
Marvell Technology has surged in 2026 as AI infrastructure demand accelerates. Here is a timely look at the case for ...
A stunning earnings moment has sparked questions about AMD's role in AI infrastructure. This deep-dive breaks down wh...
In a choppy market, one defense contractor shines as a rare dividend stock built for downturns. Its government-backed...
Bitcoin sits in a delicate consolidation phase as traders grapple with potentially game-changing levels. On-chain dat...
The ITA ETF just ripped higher again, underscoring a multi-year upcycle in America’s rearmament push. Here’s what inv...
SpaceX rumors spark a rally in the Procure Space ETF, with the fund tracking the space economy as investors eye a pot...
SK Hynix’s record Nasdaq debut raises $26.5 billion, underscoring persistent AI memory demand as markets grapple with...